Clinical Trial Update: Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 [Phase 3]

View source ↗

Summary

A Phase 3 study (ECZTRA 3) evaluating tralokinumab in combination with topical corticosteroids for moderate to severe atopic dermatitis has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2021-01-14